146 related articles for article (PubMed ID: 28716526)
21. Oncogenic non-coding RNA NEAT1 promotes the prostate cancer cell growth through the SRC3/IGF1R/AKT pathway.
Xiong W; Huang C; Deng H; Jian C; Zen C; Ye K; Zhong Z; Zhao X; Zhu L
Int J Biochem Cell Biol; 2018 Jan; 94():125-132. PubMed ID: 29225160
[TBL] [Abstract][Full Text] [Related]
22. Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer models.
Ateeq B; Vellaichamy A; Tomlins SA; Wang R; Cao Q; Lonigro RJ; Pienta KJ; Varambally S
Prostate; 2012 Oct; 72(14):1542-9. PubMed ID: 22415461
[TBL] [Abstract][Full Text] [Related]
23. Nelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancer.
Guan M; Fousek K; Chow WA
FEBS J; 2012 Jul; 279(13):2399-411. PubMed ID: 22540830
[TBL] [Abstract][Full Text] [Related]
24. The landscape of chimeric RNAs in bladder urothelial carcinoma.
Zhu D; Singh S; Chen X; Zheng Z; Huang J; Lin T; Li H
Int J Biochem Cell Biol; 2019 May; 110():50-58. PubMed ID: 30818082
[TBL] [Abstract][Full Text] [Related]
25. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.
Hermans KG; van Marion R; van Dekken H; Jenster G; van Weerden WM; Trapman J
Cancer Res; 2006 Nov; 66(22):10658-63. PubMed ID: 17108102
[TBL] [Abstract][Full Text] [Related]
26. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
[TBL] [Abstract][Full Text] [Related]
27. Recurrent fusion RNA DUS4L-BCAP29 in non-cancer human tissues and cells.
Tang Y; Qin F; Liu A; Li H
Oncotarget; 2017 May; 8(19):31415-31423. PubMed ID: 28415823
[TBL] [Abstract][Full Text] [Related]
28. FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer.
Paulo P; Barros-Silva JD; Ribeiro FR; Ramalho-Carvalho J; Jerónimo C; Henrique R; Lind GE; Skotheim RI; Lothe RA; Teixeira MR
Genes Chromosomes Cancer; 2012 Mar; 51(3):240-9. PubMed ID: 22081504
[TBL] [Abstract][Full Text] [Related]
29. TMPRSS2-ERG fusion protein regulates insulin-like growth factor-1 receptor (IGF1R) gene expression in prostate cancer: involvement of transcription factor Sp1.
Meisel Sharon S; Pozniak Y; Geiger T; Werner H
Oncotarget; 2016 Aug; 7(32):51375-51392. PubMed ID: 27285981
[TBL] [Abstract][Full Text] [Related]
30. Nuclear export of chimeric mRNAs depends on an lncRNA-triggered autoregulatory loop in blood malignancies.
Chen ZH; Chen TQ; Zeng ZC; Wang D; Han C; Sun YM; Huang W; Sun LY; Fang K; Chen YQ; Luo XQ; Wang WT
Cell Death Dis; 2020 Jul; 11(7):566. PubMed ID: 32703936
[TBL] [Abstract][Full Text] [Related]
31. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?
Walsh AL; Tuzova AV; Bolton EM; Lynch TH; Perry AS
Trends Mol Med; 2014 Aug; 20(8):428-36. PubMed ID: 24836411
[TBL] [Abstract][Full Text] [Related]
33. Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer.
Butler MS; Roshan-Moniri M; Hsing M; Lau D; Kim A; Yen P; Mroczek M; Nouri M; Lien S; Axerio-Cilies P; Dalal K; Yau C; Ghaidi F; Guo Y; Yamazaki T; Lawn S; Gleave ME; Gregory-Evans CY; McIntosh LP; Cox ME; Rennie PS; Cherkasov A
Oncotarget; 2017 Jun; 8(26):42438-42454. PubMed ID: 28465491
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
[TBL] [Abstract][Full Text] [Related]
35. Chimeric RNAs generated by intergenic splicing in normal and cancer cells.
Jividen K; Li H
Genes Chromosomes Cancer; 2014 Dec; 53(12):963-71. PubMed ID: 25131334
[TBL] [Abstract][Full Text] [Related]
36. Abnormal expression of the ERG transcription factor in prostate cancer cells activates osteopontin.
Flajollet S; Tian TV; Flourens A; Tomavo N; Villers A; Bonnelye E; Aubert S; Leroy X; Duterque-Coquillaud M
Mol Cancer Res; 2011 Jul; 9(7):914-24. PubMed ID: 21669963
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines.
Pickard MR; Mourtada-Maarabouni M; Williams GT
Biochim Biophys Acta; 2013 Oct; 1832(10):1613-23. PubMed ID: 23676682
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer.
Su W; Xu M; Chen X; Chen N; Gong J; Nie L; Li L; Li X; Zhang M; Zhou Q
Mol Cancer; 2017 Aug; 16(1):142. PubMed ID: 28830551
[TBL] [Abstract][Full Text] [Related]
39. Integrative Analysis of Normal Long Intergenic Non-Coding RNAs in Prostate Cancer.
Bawa P; Zackaria S; Verma M; Gupta S; Srivatsan R; Chaudhary B; Srinivasan S
PLoS One; 2015; 10(5):e0122143. PubMed ID: 25933431
[TBL] [Abstract][Full Text] [Related]
40. The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer.
Crea F; Venalainen E; Ci X; Cheng H; Pikor L; Parolia A; Xue H; Nur Saidy NR; Lin D; Lam W; Collins C; Wang Y
Epigenomics; 2016 May; 8(5):721-31. PubMed ID: 27096814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
